# Immunosuppressant Regimens for Living Fetuses Study

> **NCT03671174** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 420 (estimated)

## Conditions studied

- Undifferentiated Connective Tissue Disease
- Recurrent Pregnancy Loss

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Hydroxychloroquine
- **DRUG:** Aspirin
- **DRUG:** low molecular weight heparin

## Key facts

- **NCT ID:** NCT03671174
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-02
- **Primary completion:** 2021-09
- **Final completion:** 2023-02
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2019-08-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03671174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03671174, "Immunosuppressant Regimens for Living Fetuses Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03671174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*